Company: HCTI
Filing Date: 2025-05-15
Form Type: 424B4
Source: 0001213900-25-044095
Chunk: 25

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-15
Form: 424B4
Chunk 25
---
 for
the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise
or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon
the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common
Stock, other than in connection with customary anti-dilution adjustments resulting from future stock splits, stock dividends or similar
transactions, or (ii) issues or sells any amortizing convertible security that amortizes prior to its maturity date, whereby it is required
to or has the option to (or the investor in such security has the option to require the Company to) make such amortization payments in
Common Stock (whether or not such payments in stock are subject to certain equity conditions) or (iii) enters into, or effects a transaction
under, any agreement, including, but not limited to, an equity line of credit or “at-the-market” offering, whereby it may
sell securities at a future determined price, regardless of whether shares of Common Stock pursuant to such agreement have actually been
issued and regardless of whether such agreement is subsequently canceled, provided that any issuance of Shares (1) issued in connection
with the Securities Purchase Agreement dated December 28, 2023 between the Company and L1 Capital Global Opportunities Master Fund Ltd
or any of the transaction documents related thereto (collectively, The “L1 Transaction Documents”) excluding any amendments
or restatements of such L1 Transaction Documents or (2) upon the exercise of the Purchase Warrants will not be deemed a Variable Rate
Transaction.

The Company has also entered
into a Registration Rights Agreement (the “Registration Rights Agreement”) dated February 28, 2025 with the selling stockholders
pursuant which we agreed to file the Registration Statement for all of the Registrable Securities within five (5) calendar days of filing
its Annual Report on Form 10-K for fiscal year 2024 and has agreed that the Registration Statement shall be effective no later than 45
days after the filing of such 10-K (if the Securities and Exchange Commission (the “SEC”) has no comments on the Registration
statement and no later than 75 days after the filing of such 10-K if the SEC does have comments. The Company has agreed to pay a daily
penalty to the selling stockholders equal to 0.1%